Advancing the measurement of favorable selection in Medicare Advantage: evidence from encounter data
Health Affairs Scholar · 03.07.2026 · 4 (7)
DOI: 10.1093/haschl/qxag182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Affairs Scholar, online erschienen am 10.07.2026. Verfasst von Debra Bozzi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Humana Healthcare Research, Louisville, KY 40202, United States. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Debate persists over how favorable selection in Medicare Advantage (MA) affects federal spending relative to Traditional Medicare (TM). Prior studies, including the Medicare Payment Advisory Commission's (MedPAC's) March 2025 Report, focus on TM-to-MA switchers—roughly one-third of MA enrollees—but extrapolating these findings to the broader MA population is sensitive to identifying assumptions because switchers’ cost patterns may differ from non-switchers. This study uses MA encounter data to compare switchers and non-switchers and assess an alternative extrapolation approach to estimating favorable selection.
Methods
We estimated favorable selection among 1.4 million MA enrollees from 2020 to 2022, generating separate estimates for switchers and non-switchers. Using a 5% national Medicare sample, we attempted to replicate MedPAC's switcher-based analysis, then modified its extrapolation by comparing risk-adjusted costs (imputed with TM claims) between switchers and non-switchers using MA encounter data.
Results
Favorable selection ranged from 4.9% to 5.8% between 2020 and 2022—32% to 40% lower than our attempted replication of MedPAC's estimate (8.2%-8.8%).
Conclusion
Using an alternative extrapolation approach lowered favorable selection, underscoring its sensitivity to methods and the importance of further refinement for MA payment policy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Humana Healthcare Research, Louisville, KY 40202, United States.
- Humana, Inc., Louisville, KY 40202, United States.
ORCID-Profile: Debra Bozzi, Ariel Caplan, Jared Doom, Yong Li
Zitieren
APA
Bozzi, D., Caplan, A., Doom, J., Boudreau, E., Hartjes, M., Schwartz, R., Li, Y., Ray, A., & Sylwestrzak, G. (2026). Advancing the measurement of favorable selection in Medicare Advantage: evidence from encounter data. Health Affairs Scholar, 4(7). https://doi.org/10.1093/haschl/qxag182
Vancouver
Bozzi D, Caplan A, Doom J, Boudreau E, Hartjes M, Schwartz R, et al. Advancing the measurement of favorable selection in Medicare Advantage: evidence from encounter data. Health Affairs Scholar. 2026;4(7). doi:10.1093/haschl/qxag182
BibTeX
@article{Bozzi2026,
author = {Bozzi, Debra and Caplan, Ariel and Doom, Jared and Boudreau, Emily and Hartjes, Mike and Schwartz, Richard and Li, Yong and Ray, Ashley and Sylwestrzak, Gosia},
title = {Advancing the measurement of favorable selection in Medicare Advantage: evidence from encounter data},
journal = {Health Affairs Scholar},
year = {2026},
volume = {4},
number = {7},
doi = {10.1093/haschl/qxag182}
}
EUVIMED